论文部分内容阅读
血管紧张素受体拮抗剂对肾素血管紧张素系统终端受体的阻断具有较血管紧张素转换酶抑制剂更好的耐受而逐步广泛地应用于临床。本文综述了坎地沙坦在降压、靶器官保护、防治心力衰竭以及冠心病中的近期研究成果。
Angiotensin receptor blockers have been widely used clinically for their blockade of the renin-angiotensin system terminal receptor compared with angiotensin-converting enzyme inhibitors. This article reviews the recent progress of candesartan in lowering blood pressure, protecting target organs, preventing heart failure and coronary heart disease.